Abstract
Background and Objectives: To determine the risk of mortality and causes of death in persons with late-onset epilepsy (LOE) compared to those without epilepsy in a community-based sample, adjusting for demographics and comorbid conditions. Methods: This is an analysis of the prospective Atherosclerosis Risk in Communities study, initiated in 1987-1989 among 15,792 mostly Black and White men and women in 4 US communities. We used Centers for Medicare & Medicaid Services fee-for-service claims codes to identify cases of incident epilepsy starting at or after age 67. We used Cox proportional hazards analysis to identify the hazard of mortality associated with LOE and to adjust for demographics and vascular risk factors. We used death certificate data to identify dates and causes of death. Results: Analyses included 9,090 participants, of whom 678 developed LOE during median 11.5 years of follow-up after age 67. Participants who developed LOE were at an increased hazard of mortality compared to those who did not, with adjusted hazard ratio 2.39 (95% confidence interval 2.12-2.71). We observed excess mortality due to stroke, dementia, neurologic conditions, and end-stage renal disease in participants with compared to without LOE. Only 4 deaths (1.1%) were directly attributed to seizure-related causes. Conclusions: Persons who develop LOE are at increased risk of death compared to those without epilepsy, even after adjusting for comorbidities. The majority of this excess mortality is due to stroke and dementia.
| Original language | English |
|---|---|
| Pages (from-to) | E1132-E1140 |
| Journal | Neurology |
| Volume | 97 |
| Issue number | 11 |
| DOIs | |
| State | Published - Sep 14 2021 |
Bibliographical note
Publisher Copyright:© 2021 American Academy of Neurology.
Funding
The Atherosclerosis Risk in Communities study has been funded in whole or in part with federal funds from the National Heart, Lung, and Blood Institute, NIH, Department of Health and Human Services, under contract numbers HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700004I, and HHSN268201700005I. Neurocognitive data are obtained by grants U01 HL096812, U01 HL096814, U01 HL096899, U01 HL096902, and U01 HL096917 from the National Heart, Lung, and Blood Institute, with funding also provided by the National Institute of Neurological Disorders and Stroke and National Institute on Aging. This study was also supported by contracts K23 AG063899 (Dr. Johnson) and K24 AG052573 (Dr. Gottesman) from the National Institute on Aging.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | |
| U.S. Department of Health and Human Services | U01 HL096814, U01 HL096902, U01 HL096899, U01 HL096812, HHSN268201700003I, HHSN268201700004I, HHSN268201700005I, U01 HL096917, HHSN268201700001I, HHSN268201700002I |
| U.S. Department of Health and Human Services | |
| National Institute on Aging | K23 AG063899, K24 AG052573 |
| National Institute on Aging | |
| National Heart, Lung, and Blood Institute (NHLBI) | U01HL096812 |
| National Heart, Lung, and Blood Institute (NHLBI) | |
| Institute of Neurological Disorders and Stroke National Advisory Neurological Disorders and Stroke Council |
ASJC Scopus subject areas
- Clinical Neurology
Fingerprint
Dive into the research topics of 'Mortality in Patients With Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver